Effects of panitumumab on the proteome of treated EGFRvIII glioblastoma cells and on their extracellular vesicles
Glioblastoma (GB) is an aggressive brain tumor for which reliable biomarkers of therapeutic response are still needed. Extracellular vesicles (EVs) can car